Form 8-K - Current report:
SEC Accession No. 0001193125-24-255166
Filing Date
2024-11-12
Accepted
2024-11-12 07:44:02
Documents
38
Period of Report
2024-11-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d793839d8k.htm   iXBRL 8-K 25388
2 EX-99.1 d793839dex991.htm EX-99.1 73637
3 EX-99.2 d793839dex992.htm EX-99.2 33823
7 GRAPHIC g793839ex99_2s10g1.jpg GRAPHIC 109043
8 GRAPHIC g793839ex99_2s11g1.jpg GRAPHIC 130118
9 GRAPHIC g793839ex99_2s12g1.jpg GRAPHIC 104089
10 GRAPHIC g793839ex99_2s13g1.jpg GRAPHIC 132385
11 GRAPHIC g793839ex99_2s14g1.jpg GRAPHIC 107135
12 GRAPHIC g793839ex99_2s15g1.jpg GRAPHIC 125763
13 GRAPHIC g793839ex99_2s16g1.jpg GRAPHIC 90730
14 GRAPHIC g793839ex99_2s17g1.jpg GRAPHIC 94342
15 GRAPHIC g793839ex99_2s18g1.jpg GRAPHIC 80576
16 GRAPHIC g793839ex99_2s19g1.jpg GRAPHIC 89740
17 GRAPHIC g793839ex99_2s1g1.jpg GRAPHIC 57254
18 GRAPHIC g793839ex99_2s20g1.jpg GRAPHIC 123633
19 GRAPHIC g793839ex99_2s21g1.jpg GRAPHIC 118890
20 GRAPHIC g793839ex99_2s22g1.jpg GRAPHIC 56553
21 GRAPHIC g793839ex99_2s2g1.jpg GRAPHIC 243743
22 GRAPHIC g793839ex99_2s3g1.jpg GRAPHIC 148006
23 GRAPHIC g793839ex99_2s4g1.jpg GRAPHIC 105870
24 GRAPHIC g793839ex99_2s5g1.jpg GRAPHIC 114032
25 GRAPHIC g793839ex99_2s6g1.jpg GRAPHIC 104660
26 GRAPHIC g793839ex99_2s7g1.jpg GRAPHIC 90881
27 GRAPHIC g793839ex99_2s8g1.jpg GRAPHIC 107592
28 GRAPHIC g793839ex99_2s9g1.jpg GRAPHIC 92562
29 GRAPHIC g793839snap1.jpg GRAPHIC 15981
  Complete submission text file 0001193125-24-255166.txt   3651021

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA bcax-20241112.xsd EX-101.SCH 2878
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcax-20241112_lab.xml EX-101.LAB 18738
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcax-20241112_pre.xml EX-101.PRE 11726
40 EXTRACTED XBRL INSTANCE DOCUMENT d793839d8k_htm.xml XML 3760
Mailing Address 245 MAIN STREET CAMBRIDGE MA 02142
Business Address 245 MAIN STREET CAMBRIDGE MA 02142 617-785-8308
Bicara Therapeutics Inc. (Filer) CIK: 0002023658 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42271 | Film No.: 241443373
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)